DavidAllenBrennerMD
Gastroenterology • La Jolla, CAVice Chancellor ofr Health Sciences and Dean, School of Medicine at UC San Diego
Dr. Brenner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9300 Campus Point Dr
La Jolla, CA 92037Phone+1 858-657-8381Fax+1 858-822-0084
Education & Training
University of California (San Diego) Medical CenterFellowship, Gastroenterology, 1985 - 1988- University of California (San Diego) Medical CenterResidency, Internal Medicine, 1985 - 1986
NIH Clinical CenterPost-Doctoral Fellowship, 1982 - 1985
Yale-New Haven Medical CenterResidency, Internal Medicine, 1979 - 1982
Yale School of MedicineClass of 1979
Certifications & Licensure
CA State Medical License 1985 - 2025
NY State Medical License 2003 - 2009
NC State Medical License 1993 - 2004
MD State Medical License 1982 - 1986- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Bomedical Scholar Pew Foundation, 1986
- Fellow (FACP) American College of Physicians, 2005
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Alpha-1 Antitrypsin Deficiency Adult Liver Study Start of enrollment: 2013 Dec 01
Publications & Presentations
PubMed
- 1 citationsAlternatives to animal testing to assess MASH drugs and hepatotoxicity.David A Brenner
Hepatology. 2025-01-01 - Fibrosis, biomarkers and liver biopsy in AAT deficiency and relation to liver Z protein polymer accumulation.Anandini Suri, Zidong Zhang, Brent Neuschwander-Tetri, David A Lomas, Nina Heyer-Chauhan
Liver International. 2024-12-01 - Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease.Rohit Loomba, Ginger Clark, Jeff Teckman, Veeral Ajmera, Cynthia Behling
Alimentary Pharmacology & Therapeutics. 2024-05-01
Press Mentions
Role of Macrophages in Fatty Liver Disease OutcomesAugust 24th, 2024- Macrophage Mix Helps Determine Rate and Fate of Fatty Liver DiseaseAugust 22nd, 2024
- Macrophage Mix Helps Determine Rate and Fate of Fatty Liver DiseaseAugust 22nd, 2024
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
